MISOFAR
Trade name:
MISOFAR 25 mcg N8 vaginal tablets
Cod ATC:
G02AD06
Active substance:
Dosage:
Manufacturer
BIAL – Portela & Cª À Avenida da Siderurgia Nacional, 4745-457 Coronado (S. Romão e S. Mamede), Portugal
Therapeutic indications:
MISOFAR 25 is a synthetic prostaglandin E1 indicated in obstetrics and gynecology, including medical management of miscarriage, induction of labor, cervical ripening before surgical procedures, and in the treatment of postpartum hemorrhage.
Description:
MISOFAR vaginal tablets is the only pharmaceutical form of misoprostol, used in obstetrics and gynecology. Clinical efficacy of misoprostol in vaginal tablets increases compared with other forms, assuring a constant plasma concentration, while decreasing the side effects specific to misoprostol products.
Pharmacovigilance
Information about drug safety
Pharmacovigilance is the science and activities related to the detection, evaluation, understanding and prevention of adverse effects or any other problem related to medicines.
